Rosal 2005.
Methods |
Parallel randomised controlled clinical trial (RCT) (pilot) Randomisation ratio: assumed 3:2 Superiority design |
|
Participants |
Inclusion criteria:
Exclusion criteria:
Diagnostic criteria: not stated Participating population: individuals (in a community with 80% Puerto Rican heritage) with type 2 DM > 18 years of age |
|
Interventions |
Number of study centres: 1 community health centre, an affiliated elder health centre and a community‐wide database Treatment before study: not stated Number of study centres: not stated Intervention: consisted of an initial 1‐hour individual session, followed by 2 3‐hour weekly group sessions for 10 weeks and 2 15‐minute sessions. individual sessions during the 10‐week period. Primary care physicians received copies of laboratory results at each assessment point Control: Usual care and primary care physicians received copies of laboratory results as intervention group did Provider: bilingual nutritionist, diabetes nurse and assistant |
|
Outcomes |
Outcomes reported in abstract of publication: Primary outcome(s):
Secondary outcome(s): Not specified between primary and secondary outcomes |
|
Study details |
Run‐in period: not stated Study terminated before regular end: no |
|
Publication details |
Language of publication: English Funding: American Diabetes Association Innovation Award, which in part is supported by NovoNordisk Pharmaceuticals Publication status: peer‐reviewed journal |
|
Stated aim of study | Quote from publication: "To assess the feasibility of an innovative self‐management education in low income Spanish speaking individuals and secondly to have a preliminary data of intervention effects" | |
Notes | — | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Comment: method of randomisation not specified |
Allocation concealment (selection bias) | Unclear risk | Quote from publication: "Research assistants administered informed consent documents ... and were blind to the random sequence allocation" Comment: does not specify method of allocation concealment |
Blinding of participants and personnel (performance bias) Objective outcomes | High risk | Comment: providers not blinded because of the nature of the intervention; participants unlikely to have been blinded |
Blinding of participants and personnel (performance bias) Subjective outcomes | High risk | Comment: providers not blinded because of the nature of the intervention; participants unlikely to have been blinded |
Blinding of outcome assessment (detection bias) Lab tests: Lipids, HBA1C | Low risk | Comment: does not say whether research assistants taking blood pressure were blinded. However, details given for standardised procedure for doing this |
Blinding of outcome assessment (detection bias) Subjective outcomes | High risk | Comment: participants completing questionnaires unlikely to have been blinded |
Incomplete outcome data (attrition bias) Objective outcomes | Unclear risk | Comment: does not mention whether any participants were lost to follow‐up; no numbers in results and no mention of whether ITT analysis was used |
Incomplete outcome data (attrition bias) Subjective outcomes | Unclear risk | Comment: does not mention whether any participants were lost to follow‐up; no numbers in results and no mention of whether ITT analysis was used |
Selective reporting (reporting bias) | Unclear risk | Comment: no outcomes appear unreported but protocol not seen |
Other bias | Unclear risk | Comment: none |